Introduction
ter in families [10] , and there is an increased prevalence of both hypertension [11] and coronary heart disease The concept of microalbuminuria was introduced more [12] among the non-diabetic parents of patients with than 30 years ago when it became possible to measure nephropathy. With regard to NIDDM, it has been concentrations of urinary albumin below the level of reported that non-diabetic relatives of NIDDM detection of a urinary protein dipstick [1] . By the early patients with microalbuminuria have an elevated albu1980s, microalbuminuria had been shown to predict min excretion rate [13] . These observations have been the development of nephropathy in insulin-dependent taken to imply that a common predisposition, possibly diabetic (IDDM ) patients [2] , leading to the view that of genetic origin, may underlie both the familial clusthe excretion of increased amounts of urinary albumin tering of microalbuminuria and its link to cardiovasin these patients was an early manifestation of the cular disease. pathophysiological process which, as a final conRecent studies, however, have suggested a substansequence, led to renal failure.
tial heterogeneity in the phenotypic characteristics of Microalbuminuria also predicts dipstick-positive microalbuminuric diabetic patients. These findings proteinuria and nephropathy in patients with nonraise the possibility of a more diverse aetiology of insulin-dependent diabetes (NIDDM ) [3] , but in these microalbuminuria, which in turn challenges current patients its major prognostic significance is for thinking about the nature of its link with cardiovasincreased cardiovascular risk [4] . More recent observacular disease. We propose that microalbuminuria in tions have extended the concept of microalbuminuria diabetes is heterogeneous with respect to clinical feaas a risk marker for cardiovascular disease to subjects tures and renal histology. We suggest that this heterowithout diabetes, in whom an elevated albumin excregeneity has conceptual, prognostic and therapeutic tion rate has been shown to predict a mortality up to implications, and so is of clinical importance. 24 times that of normoalbuminuric subjects [5] . Furthermore, in IDDM patients, both dipstick-positive tion of von Willebrand factor, a marker of endothelial nuria and cardiovascular disease risk, in that microalbuminuria was associated with an increased risk of dysfunction, but only in subjects with photographic evidence of diabetic retinopathy. Around half of the new cardiovascular events only when endothelial dysfunction was present [15] . Thus, both in IDDM and, patients with microalbuminuria had no clinical evidence of retinopathy, and in this group there was no perhaps even more so, in NIDDM, the interrelationships among microalbuminuria, endothelial dysassociation of increasing albumin excretion with either blood pressure or endothelial dysfunction.
function, renal histology and diabetic retinopathy are clearly heterogeneous. In IDDM patients with dipstick-positive proteinuria, renal histology shows mesangial expansion, increased glomerular basement membrane width and arteriolar Microalbuminuria in diabetes mellitus: a new hyalinosis [21] . In general, patients with microalbuminclassification with aetiological and prognostic uria have similar but less extensive structural lesions implications [21, 22] , but their severity is quite wide, ranging from values observed in normoalbuminuric patients to those observed in patients with overt proteinuria [21] [22] [23] [24] . We speculate that microalbuminuria in diabetes may have at least two, and possibly three, different aetiologThis variability is in keeping with the observation that not all IDDM patients with microalbuminuria progress ies. To begin with, there appears to be one aetiology that involves a close link with generalized endothelial to overt proteinuria [20] . Renal structure in IDDM has not been investigated in relation to endothelial damage, and one that does not. We hypothesize that only microalbuminuria with generalized endothelial dysfunction, but the presence of retinopathy and hypertension (which, as noted above, are closely related to damage confers an increased risk of cardiovascular disease and renal failure. In other words, we postulate endothelial dysfunction [18]) was associated with an increase in both mesangial volume and basement mem-that microalbuminuria may be 'benign' or 'malignant'.
In addition, the recent findings on the interrelationships brane width which was independent of the albumin excretion rate [25] .
between endothelial dysfunction, renal histology and severity of diabetic retinopathy in NIDDM [14, 19, 28] In NIDDM, microalbuminuric patients have increased blood pressure and more severe retinopathy raise the possibility of two subcategories of 'malignant' microalbuminuria in diabetes: one involving glycaemic and endothelial dysfunction than do normoalbuminuric patients [15, 26 ] . Again, however, there is import-and the other non-glycaemic pathways of vascular and endothelial injury. The fact that endothelial dysfuncant heterogeneity among these associations [14, 15, 19] ; in addition, there is some evidence-although by no tion is related to the atypical pattern of renal injury in NIDDM [14, 19, 28] may then be explained by postulatmeans undisputed-that both dipstick-positive proteinuria [27] and microalbuminuria [28] are morpho-ing that this process does have a vascular aetiology, but one that depends less (or perhaps not at all ) on logically heterogeneous. Parving and colleagues performed renal biopsies in 35 NIDDM patients with hyperglycaemia than does typical diabetic glomerulopathy. This would also explain the occurrence of less persistent albuminuria and found typical diabetic nephropathy in 77%, about two-thirds of whom had severe diabetic retinopathy in the group with atypical renal histology than in those with typical diabetic diabetic retinopathy, vs none among patients with nondiabetic renal histological abnormalities [27] . Fioretto glomerulopathy [28] , because this latter group would have more severe specifically diabetic microvascular and colleagues biopsied 34 microalbuminuric patients and found changes typical of diabetic nephropathy in disease (of which proliferative diabetic retinopathy is a marker), while vascular damage in the former group only 30%, whereas 30% had normal or near-normal histology. The remaining 40% had tubulointerstitial would tend to be of both glycaemic and non-glycaemic origin. The prognostic implications of these hypotheses abnormalities and (or) arteriolar hyalinosis and global glomerular sclerosis, but no or minimal diabetic glo-are summarized in Table 1 .
A more precise phenotypic characterization of merulopathy, a pattern of injury they termed 'atypical' [28] . Proliferative retinopathy was observed only microalbuminuric subjects is necessary to assess the role of genetic and environmental determinants of the among those microalbuminuric patients who had typical diabetic glomerulopathy [28] . Fioretto et al. have diverse types of microalbuminuria proposed above.
For example, early growth retardation, abnormalities shown recently that endothelial dysfunction, as estimated by plasma von Willebrand factor concentration, of sodium membrane transport, increased production of vascular endothelial growth factor, or polymorphwas present only in those microalbuminuric patients who, on renal biopsy, had either typical diabetic glo-isms in the constitutive nitric oxide synthase gene could predispose to the types of microalbuminuria that are merulopathy or atypical patterns of injury but not in those with (near-) normal histology [19] . associated with endothelial dysfunction, while polymorphisms in genes controlling the activity of intraSuch different phenotypic patterns may imply heterogeneity of aetiology and prognosis. In fact, in a renal haemodynamics might lead to glomerular hypertension and microalbuminuria but not necessarily prospective study in NIDDM, Stehouwer et al. have shown that the presence of endothelial dysfunction, as to generalized endothelial dysfunction. We further speculate that, in contrast to the other categories estimated by elevated plasma levels of von Willebrand factor, modified the relationship between microalbumi-shown in Table 1 , the category characterized by microalbuminuria, endothelial dysfunction, typical dia-aged and elderly subjects [5] . Therefore, both the occurrence of microalbuminuria and the link between betic glomerulopathy and severe retinopathy has its pathophysiological basis in biochemical alterations microalbuminuria and cardiovascular disease do not necessarily require the presence of diabetes, i.e. they specifically linked to hyperglycaemia, such as hyperglycaemic pseudohypoxia, protein kinase C activation and can occur through a diabetic or a non-diabetic pathway. We hypothesized above that the diabetic pathway advanced glycation end-product formation.
This new classification of microalbuminuria pro-involves damage to the vascular endothelium. Only a few small cross-sectional studies have addressed the posed here emphasizes that we need to address the nature of the link between microalbuminuria and endo-question of whether a similar mechanism operates among non-diabetic subjects, with inconclusive results thelial dysfunction. For example, endothelial dysfunction might directly cause microalbuminuria both by [30] [31] [32] . Moreover, other mechanisms unrelated to endothelial dysfunction need to be considered, such as contributing to the synthesis of a leaky glomerular basement membrane and by influencing glomerular a primary increase in vascular permeability [31, 33] and matrix composition, and functional abnormalities in mesangial and epithelial cell function in a paracrine fashion. Alternatively, both generalized endothelial vascular smooth muscle cells, monocytes-macrophages or renal mesangial cells. Thus, data are as yet insuffidysfunction and microalbuminuria might develop in parallel as a result of some common underlying patho-cient to support the idea that microalbuminuria and its link with cardiovascular disease have similar origins physiological process, for which there is no lack of contenders but no definite proof [29] .
in diabetic and non-diabetic subjects. It is also unknown whether microalbuminuria in non-diabetic Finally, a hypothesis of aetiological diversity in microalbuminuria could lead to differences in the subjects may be prognostically heterogeneous ('benign' or 'malignant'). In comparison with diabetes, microtherapeutic approaches indicated in such subjects. Microalbuminuric patients with endothelial dysfunc-albuminuria in non-diabetic subjects has as yet tion may merit especially intensive efforts with respect been poorly characterized both phenotypically and to the treatment of conventional cardiovascular risk histologically. factors. Moreover, a better understanding of the nature of endothelial dysfunction in diabetes might lead Conclusion to more specific therapies, such as with free radical scavengers or glycosaminoglycans. While such consequences of heterogeneity of microalbuminuria are as We propose that microalbuminuria in diabetes mellitus yet speculative, each of them is amenable to epidemio-is heterogeneous: benign and malignant. It may be logical, clinical or experimental verification. For associated with generalized endothelial dysfunction, example, an important test of our hypothesis is to severe diabetic retinopathy and cardiovascular disease, investigate whether treatments such as those with free or it may lack such associations. This classification, if radical scavengers do or do not improve endothelial correct, has important prognostic, aetiological and function and microalbuminuria in parallel. If 'benign possibly therapeutic implications. We emphasize, howmicroalbuminuria' does exist, we would expect some ever, that our hypothesis at present is no more than microalbuminuric patients to have normal endothelial an agenda for further research that has yet to be tested function and no reaction to such treatment.
vigorously. In clinical practice, the presence of microalbuminuria should be regarded as a powerful indicator of an increased risk of renal failure and cardiovascular 
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